Company / PP&E per Share
Xeris Biopharma Holdings, Inc. PP&E per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.03
FY2025
5-year range
$0.03 / $0.16
FY2021-FY2025
Trend
-17.8%
vs FY2024
Sector context
#131 of 191
Health Care
What the data says
At $0.03, Xeris Biopharma Holdings, Inc.'s pp&e per share ranks #131 of 191 in the Health Care sector. PP&E per Share has declined for 5 consecutive years, from $0.16 in FY2020 to $0.03 in FY2025.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -26.8%.
Declined from $0.04 to $0.03 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -9.2%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Sector benchmark
#131 of 191 in Health CareTop 69% of 191This company $0.03 Sector average $22.34
▼
-99.9% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s pp&e per share has declined for 5 consecutive years.
- In FY2025, pp&e per share decreased 17.8% year-over-year.
- Ranks #131 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -17.8% |
| FY2024 | $0.04 | -8.1% |
| FY2023 | $0.04 | -0.8% |
| FY2022 | $0.04 | -71.6% |
| FY2021 | $0.16 | -1.2% |
| FY2020 | $0.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026